GGrantIndex
Sort

53,477 grants matching addiction

Buprenorphine for Prisoners

$542,471
Timothy W Kinlock · Friends Research Institute, Inc. · R01 · FY2010 · DA

Effects of State Laws to Reduce Opioid Diversion on Transitions to Injection Drug Use and HIV/HCV Transmission

$542,464
Julia B Dickson-Gomez · Medical College Of Wisconsin · R01 · FY2022 · DA

MOUD Comparative Effectiveness Study

$542,395
Marc Larochelle · Boston Medical Center · R01 · FY2024 · DA

MOUD Comparative Effectiveness Study

$542,395
Marc Larochelle · Boston Medical Center · R01 · FY2025 · DA

Sustainable HIV Risk Reduction Strategies for CJ Systems

$542,370
Wayne E.k. Lehman · Texas Christian University · R01 · FY2009 · DA

Cholinergic regulation of striatal neurochemistry in cue-triggered decision-making

$542,343
Sean Bjorn Ostlund · University Of California-Irvine · R01 · FY2016 · MH

Genomic and Physiological Impact of Transposable Elements.

$542,340
Cedric Feschotte · Cornell University · R35 · FY2024 · GM

Genomic and Physiological Impact of Transposable Elements.

$542,340
Cedric Feschotte · Cornell University · R35 · FY2025 · GM

Medical marijuana: Longitudinal trajectories in use, pain and functioning

$542,322
Mark A. Ilgen · University Of Michigan At Ann Arbor · R01 · FY2013 · DA

Pretreatment Change in Drinking: Relationship to Treatment Outcome

$542,290
Paul R Stasiewicz · State University Of New York At Buffalo · R01 · FY2014 · AA

COMMON PROTOCOL

$542,239
Barry M. Lester · Women And Infants Hospital-Rhode Island · U10 · FY2008 · DA

Maternal Lifestyle Study Phase 5

$542,239
Barry M. Lester · Women And Infants Hospital-Rhode Island · U10 · FY2008 · DA

Nature and Predictors of Impaired Harm Avoidance in Polysubstance Abuse

$542,238
Michael W. Otto · Boston University (Charles River Campus) · R33 · FY2023 · DA

Molecular Neurobiology of Human Opioid Use Disorder

$542,193
Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DA

Licit & Illicit Opioids: Comparative Studies in Humans

$542,185
Sharon L. Walsh · University Of Kentucky · R01 · FY2014 · DA

Ca2+-Dependent Block by Mematine and Selective Inhibition of Overactive NMDA Receptors

$542,179
Jon W. Johnson · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG

Ca2+-Dependent Block by Mematine and Selective Inhibition of Overactive NMDA Receptors

$542,179
Jon W. Johnson · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG

Modulating single cell types in the sensory nervous system

$542,105
Eric W Schmidt · Utah State Higher Education System--University Of Utah · R01 · FY2025 · NS

Modulating single cell types in the sensory nervous system

$542,105
Eric W Schmidt · University Of Utah · R01 · FY2022 · NS

Modulating single cell types in the sensory nervous system

$542,105
Eric W Schmidt · University Of Utah · R01 · FY2023 · NS

Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder

$542,099
Suzette M Evans · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2017 · DA

Buprenorphine for Prisoners

$542,085
Timothy W Kinlock · Friends Research Institute, Inc. · R01 · FY2008 · DA

Impacts of universal access to HIV/AIDS care among HIV+ injection drug users

$542,071
M-J Milloy · University Of British Columbia · U01 · FY2022 · DA

Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy

$542,043
Susan G Dorsey · University Of Maryland Baltimore · R01 · FY2021 · NR

The lipid hydrolase NAAA as a target for non-addictive analgesic medications

$541,998
Daniele Piomelli · University Of California-Irvine · R01 · FY2025 · DA